Priapism is defined as a prolonged penile erection in absence of sexual arousal, leading also to serious sexual and urological problems such as erectile dysfunction and penile fibrosis. Amongst many different etiologies, priapism may be caused by a wide range of antipsychotic medications, mainly due to the α1-adrenergic receptor antagonism. On the other hand, only a couple of cases of opioid compounds have been linked to the onset of priapism, with evidence coming only from methadone and buprenorphine. Here we describe the case of a patient treated with antipsychotics who developed priapism four times following rapid discontinuation of buprenorphine/naloxone (Suboxone®).

Jannini, T.b., Di Lorenzo, G., Mariano, A., Santini, R., Ciocca, G., Jannini, E.a., et al. (2022). Buprenorphine/naloxone (Suboxone®) withdrawal may facilitate antipsychotic-induced priapism: a case report. RIVISTA DI PSICHIATRIA, 57(5), 246-250 [10.1708/3893.38747].

Buprenorphine/naloxone (Suboxone®) withdrawal may facilitate antipsychotic-induced priapism: a case report

Di Lorenzo, Giorgio
;
Jannini, Emmanuele A;Siracusano, Alberto;Niolu, Cinzia
2022-01-01

Abstract

Priapism is defined as a prolonged penile erection in absence of sexual arousal, leading also to serious sexual and urological problems such as erectile dysfunction and penile fibrosis. Amongst many different etiologies, priapism may be caused by a wide range of antipsychotic medications, mainly due to the α1-adrenergic receptor antagonism. On the other hand, only a couple of cases of opioid compounds have been linked to the onset of priapism, with evidence coming only from methadone and buprenorphine. Here we describe the case of a patient treated with antipsychotics who developed priapism four times following rapid discontinuation of buprenorphine/naloxone (Suboxone®).
2022
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/25 - PSICHIATRIA
English
Adult
Analgesics, Opioid
Antisocial Personality Disorder
Buprenorphine, Naloxone Drug Combination
Chlorpromazine
Clopenthixol
Haloperidol
Humans
Male
Methadone
Receptors, Adrenergic
Antipsychotic Agents
Buprenorphine
Clozapine
Priapism
Jannini, T.b., Di Lorenzo, G., Mariano, A., Santini, R., Ciocca, G., Jannini, E.a., et al. (2022). Buprenorphine/naloxone (Suboxone®) withdrawal may facilitate antipsychotic-induced priapism: a case report. RIVISTA DI PSICHIATRIA, 57(5), 246-250 [10.1708/3893.38747].
Jannini, Tb; Di Lorenzo, G; Mariano, A; Santini, R; Ciocca, G; Jannini, Ea; Siracusano, A; Niolu, C
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/309315
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact